Inventor · disambiguated record
Eric Hoffman
Also filed as: HOFFMAN ERIC · HOFFMAN ERIC P
22 granted patents·12 pending applications·200 citations·filing 1987–2025
96Inventor score
Files withREVERAGEN BIOPHARMA INC18CHILDRENS MEDICAL CENTER3MCCALL JOHN M3HOFFMAN ERIC2HOFFMAN ERIC P2
Top patents by PatentIndex Score
34 records- 0193US10799514B2Non-hormonal steroid modulators of NF-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2016·Granted Oct 13, 2020·6 cites·18 claims
- 0292US10857161B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2018·Granted Dec 8, 2020·6 cites·21 claims
- 0392US10206933B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2017·Granted Feb 19, 2019·7 cites·14 claims
- 0492US9649320B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2016·Granted May 16, 2017·8 cites·3 claims
- 0592US8207151B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2009·Granted Jun 26, 2012·13 cites·2 claims
- 0691US8334279B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2011·Granted Dec 18, 2012·10 cites·11 claims
- 0790US9434758B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2014·Granted Sep 6, 2016·8 cites·2 claims
- 0889US9198921B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2011·Granted Dec 1, 2015·11 cites·48 claims
- 0988US11833159B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2020·Granted Dec 5, 2023·1 cites·12 claims
- 1088US8673887B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseVALIDUS GENETICS·Filed 2012·Granted Mar 18, 2014·10 cites·4 claims
- 1187US2024285650A1NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASEREVERAGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1286US11690853B2Non-hormonal steroid modulators of NF-κβ for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2020·Granted Jul 4, 2023·1 cites·13 claims
- 1383US10464967B2Non-hormonal steroid modulators of NF-κβ for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2012·Granted Nov 5, 2019·7 cites·4 claims
- 1483US5621091AProbes for and nucleic acid encoding the muscular dystrophy protein, dystrophinCHILDRENS MEDICAL CENTER·Filed 1995·Granted Apr 15, 1997·61 cites·6 claims
- 1578US2024307411A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1674US2020148717A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 1773US9188581B2Methods for diagnosing and treating asthmaFREISHTAT ROBERT J·Filed 2011·Granted Nov 17, 2015·2 cites·10 claims
- 1872US2024139210A1Treatment of nf-kb-mediated diseaseREVERAGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1971US2022324902A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2069US2025145657A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2168US9637738B2Methods and agents to increase therapeutic dystrophin expression in muscleHOFFMAN ERIC·Filed 2014·Granted May 2, 2017·1 cites·8 claims
- 2266US2022184098A1Treatment of nf-kb-mediated diseaseREVERAGEN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2366US2024299416A1TREATMENT OF NF-kB-MEDIATED DISEASEREVERAGEN BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2466US2024226117A1Treatment of congenital adrenal hypoplasiaREVERAGEN BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2563US5239060AMuscular dystrophy protein, dystrophinCHILDRENS MEDICAL CENTER·Filed 1987·Granted Aug 24, 1993·23 cites·5 claims
- 2653US10000525B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2015·Granted Jun 19, 2018·0 cites·18 claims
- 2751US2007207468A112 kb sequence immediately adjacent to and upstream of the AKT1 gene locus containing multiple genetic variations associated with changes in metabolic syndrome, and methods of useHOFFMAN ERIC P·Filed 2006·Application pending·0 cites
- 2850US2007111217A1Quantitative trait locus prognostic for changes in regional adiposity and BMI in Caucasian malesUTHURRALT JULIETA·Filed 2005·Application pending·0 cites
- 2948US2006204969A1Genetic variations (SNPs) adjacent to the AKT1 gene locus, and diagnostic and prognostic uses thereofHOFFMAN ERIC P·Filed 2005·Application pending·0 cites
- 3046US10266824B2Methods and agents to increase therapeutic dystrophin expression in muscleHOFFMAN ERIC·Filed 2017·Granted Apr 23, 2019·0 cites·6 claims
- 3145US9861642B2Methods for diagnosing and treating asthmaTHE CHILDREN'S RES INSTITUTE·Filed 2015·Granted Jan 9, 2018·0 cites·3 claims
- 3242US5541074AAntibodies to dystrophin and uses thereforCHILDRENS MEDICAL CENTER·Filed 1994·Granted Jul 30, 1996·8 cites·9 claims
- 3339US5356777AMethods of detecting periodic paralysis in horsesUNIV PITTSBURGH·Filed 1992·Granted Oct 18, 1994·13 cites·13 claims
- 3429US6268145B1Screening test for the lethal genetic trait of recurrent spontaneous pregnancy lossCHILDRENS NAT MEDICAL CT·Filed 1999·Granted Jul 31, 2001·4 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Eric Hoffman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →